A Phase 3b Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of Omadacycline to Moxifloxacin for Treating Adult Subjects With CABP

Clinical trial NCT06162286 · UNKNOWN

Trial details

NCT number: NCT06162286
Sponsor: Zai Lab (Hong Kong), Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Community-acquired Bacterial Pneumonia

Start date: 2023-11-17
Primary completion: 2025-01-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.